Moreover, the median reduction in SPAP was consistently greater in the dapagliflozin group, although this difference was only marginally significant.
← all excerpts
Pulmonary congestion relief by adding dapagliflozin to intravenous loop diuretic in acute heart failure patients.
1
—
—